C-Rad
34.30 SEK
-3.92 %
Less than 1K followers
CRAD B
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-3.92 %
+24.73 %
+22.06 %
+7.36 %
-0.72 %
+3.94 %
+10.29 %
-39.40 %
+164.16 %
C-Rad operates in the medical technology industry and focuses on the development and manufacture of systems for radiation therapy of cancer. The company's products are aimed at healthcare institutions and oncologists. The business is present on a global level, with a main presence in Europe, North America and Asia. C-Rad was founded in 2004 and is headquartered in Uppsala, Sweden.
Read moreMarket cap
1.16B SEK
Turnover
525.85K SEK
Revenue
441.9M
EBIT %
10.21 %
P/E
110.65
Dividend yield-%
0.29 %
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
17.7
2026
Interim report Q2'26
22.10
2026
Interim report Q3'26
11.2
2027
Annual report '26
All
Webcasts
Press releases
3rd party
ShowingAll content types
C-RAD marks its new chapter at ESTRO 2026 with clinician-driven SGRT advances
C-RAD's Interim Report Q1’26
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
